期刊文献+

奥氮平联合草酸艾司西酞普兰治疗老年冠心病合并抑郁症状患者的疗效观察 被引量:14

Efficacy of Olanzapine Combined with Oxalic Acid Ai Sciplan in the Treatment of Senile Coronary Heart Disease Complicated with Depression
在线阅读 下载PDF
导出
摘要 【目的】探讨奥氮平联合草酸艾司西酞普兰对老年冠心病合并抑郁症状患者的疗效。【方法】选自本院于2014年3月至2017年3月期间收治的老年冠心病合并抑郁症患者106例,按照随机数表法分为观察组与对照组各53例。对照组给予奥氮平片治疗,观察组在对照组基础上结合草酸艾司西酞普兰片治疗。两组疗程均为24周。比较两组治疗疗效,治疗前后抑郁自评量表(SDS)评分和汉密尔顿抑郁量表(HAMD)评分、血同型半胱氨酸(Hcy)和超敏C反应蛋白(hs-CRP)水平、氧化应激指标及生活质量各量表评分变化。【结果】观察组治疗总有效率(92.45%)高于对照组(73.58%),差异有显著性(P〈0.05)。两组治疗后SDS评分和HAMD评分均降低(P〈0.05),且观察组更低于对照组(tSDS=9.7886、tHAMD=16.4589,P〈0.05)。两组治疗后血清Hcy和hs-CRP水平也均降低(P〈0.05),且观察组更低于对照组(tHcy=11.3279、ths-CRP=12.8047,P〈0.05)。两组治疗后血清丙二醛(MDA)水平降低而超氧化物歧化酶(SOD)水平增加(P〈0.05);观察组治疗后血清MDA水平低于对照组而SOD水平高于对照组(tMDA=13.8751、tSOD=5.2982,P〈0.05)。两组治疗后社会关系、心理状态、生理健康和周围环境评分增加(P〈0.05),且观察组评分高于对照组(t=5.6586、7.7935、8.2064、8.3707,P〈0.05)。【结论】氮平联合草酸艾司西酞普兰对老年冠心病合并抑郁症状患者疗效明显,具有重要研究价值。 【Objective】To investigate the efficacy of olanzapine combined with oxalic acid Ai Sciplan in the treatment of senile coronary heart disease (CHD) accompanied with depressive symptoms.【Methods】A total of 106 elderly patients with coronary heart disease complicated with depression admitted from March 2014 to March 2017 in our hospital were randomly divided into an observation group (53 cases) and a control group (53 cases). The control group was treated with Olanzapine Tablets, and the observation group was treated with Escitalopram Oxalate Tablets on the basis of the control group. The two groups were treated for 24 weeks. The therapeutic effects of the two groups were compared. The scores of SDS and HAMD, Hcy and hs-CRP, indexes of oxidative stress and quality of life were evaluated before and after treatment.【Results】The total effective rate of the observation group (92.45%) was higher than that of the control group (73.58%) (P〈0.0). The SDS score and HAMD score decreased in the two groups after treatment, and the observation group was lower than the control group(tSDS=9.7886、tHAMD=16.4589, P〈0.05). After treatment, the serum Hcy and hs-CRP levels of the two groups were decreased (P〈0.05), the observation group was lower than that of the control group(tHcy=11.3279、ths-CRP=12.8047, P〈0.05); the serum malondialdehyde (MDA) levels in the two groups decreased and the superoxide dismutase (SOD) levels increased after treatment, (P〈0.05) ; the level of serum MDA in the observation group was lower than that in the control group, while the level of SOD was higher than that in the control group(tMDA=13.8751、tSOD=5.2982, P〈0.05); aftertreatment, social relations, psychological status, physical health and the surrounding environment score of the two groups increased (P〈0.05), and the observation group score were higher than the control group (t=5.6586、7.7935、8.2064、8.3707, P〈0.05).【Conclusion】Olanzapine combined with oxalic acid Ai Sciplan is effective in the treatment of elderly coronary heart disease patients with depression, and has important research value.
出处 《医学临床研究》 CAS 2017年第10期1920-1923,共4页 Journal of Clinical Research
关键词 冠心痛/并发症 抑郁症/并发症 抗精神病药/治疗应用 西酞普兰/治疗应用 Coronary Disease/CO Depressive Disorder/CO Antipsychotie Agents/TU Citalopram/TU
  • 相关文献

参考文献13

二级参考文献171

  • 1王敏建,况利.脑海马结构与抑郁障碍的关系[J].中国临床康复,2005,9(48):116-118. 被引量:9
  • 2刘卫,钱令嘉.同型半胱氨酸与抑郁[J].国际精神病学杂志,2006,33(1):45-47. 被引量:9
  • 3侯云英,范秀珍.冠心病患者抑郁情绪与生活质量的相关性研究[J].解放军护理杂志,2006,23(7):4-5. 被引量:15
  • 4雍生满,周保,栾红,徐学兵,席少静.住院冠心病病人焦虑、抑郁症状的调查[J].宁夏医学杂志,2006,28(8):606-607. 被引量:25
  • 5叶任高,陆再英.内科学[M].第7版.北京:人民卫生出版社,2008.778-779,284-297.
  • 6DAVIDSON R J,LEWIS D A,ALLOY L B, et al. Neural and behavioral substrates of mnod and mood regulation [ J]. Biological psychiatry ,2002,52 ( 6 ) :478-502.
  • 7GALECKI P, SZEMRAJ J, BIENNKIEWICZ M, et al. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment [ J ]. Pharmacological reports ,2009,61 ( 3 ) :436-447.
  • 8CATENA-DELUOSSO M, BELLANTUONO C, CONSOLI G, et al. Inflammatory neurodegenerative pathways in depression: a new avenue for antidepressant development? [ J]. Current medicinal chemistry, 2011,18(2) :245-255.
  • 9MAES M, KUBERA M, GOEHLER L,et al. Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways [ J]. Neuro endocrinology letters ,2011,32 ( l ) : 7-24.
  • 10HERKEN H, GUREL A, SELEK S, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression : impact of antidepressant treatment [ J ]. Archives of medical research ,2007,38 ( 2 ) :247-252.

共引文献194

同被引文献116

引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部